Feedback / Questions
ONS-1050 (trastuzumab biosimilar) - Zhejiang Huahai Pharma, Viropro, Syneos Health, Outlook Therap
ONS-1050: Initiation of P1 study in 2018
(Oncobiologics)
-
Aug 17, 2017 -
Pipeline Update
New P1 trial
•
Biosimilar
http://oncobiologics.com/accelsite/media/8142/Oncobiologics%20Pipeline.pdf
Aug 17, 2017
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious